News
Stewardship Prize Winner Announced
Prize Winner: Infectious Diseases Institute - Kampala, Uganda After careful review, the AMR Industry Alliance is proud to announce the Infectious Diseases Institute (IDI) in Kampala, Uganda as the...
Read more
Thomas Cueni
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 “We all have a shared responsibility to find ways f...
Read more
Dr. John Rex
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 “Antibiotics only have a finite lifetime. We only g...
Read more
Manjit Singh
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 “The AMR Industry Alliance is making a next big ste...
Read more
Dr. Larry Kerr
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 "Public-private partnerships are one of the invaluabl...
Read more
Dr. Manica Balasegaram
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 "New treatments will only be successful if they are available t...
Read more
Dr. Ramanan Laxminarayan
Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 “We certainly aren’t where we need to be with res...
Read more
World Antimicrobial Awareness Week (WAAW) 2021
As part of this year’s World Antimicrobial Awareness Week (WAAW) the AMR Industry Alliance will host a virtual panel session on Supporting the optimal use of antimicrobial medicines through inno...
Read more
Request for Proposals: Developing a sustainability framework for off-patent antibiotics
The AMR Industry Alliance is currently seeking proposals to support the work of its Access Working Group. The duration of this consultancy is defined for a period of approximately 6 months, starting 22 October 2021 (or as soon as the procurement process is completed) and ending 28 February 2022 when the deliverables have been approved by the AMR Industry Alliance Board. The consultancy will be conducted under the overall guidance of the AMR Industry Alliance Access Working Group Lead and Core Team. The Consultancy will be home-based, from any country.
Read more
Request for Proposals: Regulatory Landscape Phase 1
To view as a PDF, click here. Overview The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrobial resist...
Read more
Request for Proposals: Regulatory Landscape Phase 2
To view as a PDF, click here. Overview The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrob...
Read more
Stewardship Prize: Strengthening Stewardship and Appropriate Use in Low- and Middle-Income Countries
About the Stewardship Prize While significant efforts have been initiated across low- and middle-income countries (LMICs) to address AMR stewardship and appropriate use of antibiotics, limited resour...
Read more
AMR life sciences industry 2020 report: Successes and setbacks in fighting superbugs
AMR Industry Alliance reports breakthroughs in the responsible manufacturing of antibiotics and positive steps to improve how patients access and use antibiotics. But its report also highlights conc...
Read more
AMR Industry Alliance Round-Up, Issue No.3, November 2019
Welcome to the third issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as p...
Read more
AMR Industry Alliance Round-Up, Issue No.2, September 2019
Welcome to the second issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as...
Read more
New brochure to discover the AMR Industry Alliance in 2 minutes
Representing more than 100 biotechnology, diagnostics, generics and research-based pharmaceutical companies and associations, the AMR Industry Alliance is one of the largest private sector coalitions...
Read more
AMR Industry Alliance Round-Up, Issue No.1, June 2019
This is the first issue of "Alliance Round-Up" written for the more than 100 biotech, diagnostic, generic and pharma companies who are members of the AMR Industry Alliance, as well as people...
Read more
The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all stakeholders
The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all st...
Read more
Multiple Alliance Members Co-sign the Canadian Declaration on Antimicrobial Resistance
The International Council of Biotechnology Associations (ICBA) supports the Canadian Declaration on Combatting Antimicrobial Resistance, signed by biopharmaceutical and diagnostic companies in Canada...
Read more
Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come
The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations launches its first progress report today. The re...
Read more
New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance
New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to curb antimicrobial resistance....
Read more
AMR Roadmap Launched
Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020...
Read more
AMR Declaration Launched
More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together to call on governments and industry to work in...
Read more